“Therapeutically equivalent” means substitutable, according to the FDA’s lexicon. However, the fact that Amphastar and the FDA are still in labeling discussions (according to Amphastar) makes it less than crystal clear what the outcome will be.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”